CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 

Cumulative Scpharmaceuticals Inc 's Working Capital Ratio for Trailing Twelve Months Period

SCPH's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SCPH Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 20.97 % 31.43 % 50.6 % 62.17 % 103.11 %
Y / Y Current Assets Growth -45.45 % -37.45 % -31.13 % -27.41 % -25.26 %
Working Capital Ratio for Trailing Twelve Months Period 4.21 5.11 6.11 7.32 8.94
Total Ranking # 1075 # 1117 # 971 # 862 # 534
Seq. Current Liabilities Growth 10.64 % 8.45 % -3.83 % 4.83 % 20.21 %
Seq. Current Assets Growth -18.47 % -15.2 % -12.84 % -9.48 % -6.51 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $17 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 4.21 below Scpharmaceuticals Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 307 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Scpharmaceuticals Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 1075, from total ranking in previous quarter at 1117.

What is Working Capital Ratio?
More about SCPH
Working Capital Ratio SCPH in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 308
Sector # 561
S&P 500 # 1074


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
17.07 10.05 4.07
(Sep 30 2020)   (Sep 30 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Processa Pharmaceuticals Inc   11.56 
Tonix Pharmaceuticals Holding Corp   11.54 
Cymabay Therapeutics Inc   11.42 
Matinas Biopharma Holdings Inc   11.31 
Pulmatrix Inc   11.25 
United Therapeutics Corporation  11.22 
Decibel Therapeutics Inc   11.17 
Enanta Pharmaceuticals Inc  11.17 
Vera Therapeutics Inc   11.05 
Hoth Therapeutics Inc   11.03 
Aadi Bioscience Inc   10.95 
Xilio Therapeutics inc   10.77 
Alzamend Neuro Inc   10.71 
Monopar Therapeutics Inc   10.69 
Histogen Inc   10.69 
Allakos Inc   10.65 
Cytokinetics Incorporated  10.61 
Tango Therapeutics Inc   10.33 
Mustang Bio inc   10.33 
Guardion Health Sciences Inc   10.27 
Ironwood Pharmaceuticals inc   10.26 
Metacrine Inc   10.22 
Bicycle Therapeutics Plc  10.19 
Intra cellular Therapies Inc   10.15 
Ac Immune Sa  10.12 
Gain Therapeutics inc  10.11 
Chinook Therapeutics Inc   10.05 
Mirati Therapeutics Inc   9.98 
Applied Molecular Transport Inc   9.87 
Hepion Pharmaceuticals inc   9.86 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FRLF's Profile

Stock Price

FRLF's Financials

Business Description

Fundamentals

Charts & Quotes

FRLF's News

Suppliers

FRLF's Competitors

Customers & Markets

Economic Indicators

FRLF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071